These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35940470)

  • 1. Bone Mineral Density in Pituitary Stalk Interruption Syndrome: The Role of Insulin-Like Growth Factor-1 and Testosterone at Different Skeletal Sites.
    Zhu Y; Nie M; Wang X; Huang Q; Yu B; Zhang R; Zhang J; Sun B; Mao J; Wu X
    Endocr Pract; 2022 Nov; 28(11):1118-1124. PubMed ID: 35940470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between growth hormone deficiency and nonalcoholic fatty liver disease in patients with pituitary stalk interruption syndrome.
    Huang Q; Xu H; Wang X; Mao J; Yu B; Zhu Y; Zhang R; Sun B; Zhang J; Ji W; Ma W; Nie M; Wu X
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):612-621. PubMed ID: 35384023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia.
    Hoorweg-Nijman JJ; Kardos G; Roos JC; van Dijk HJ; Netelenbos C; Popp-Snijders C; de Ridder CM; Delemarre-van de Waal HA
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):237-44. PubMed ID: 10396368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.
    Drake WM; Rodríguez-Arnao J; Weaver JU; James IT; Coyte D; Spector TD; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN; Kandemir N
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.
    Scacchi M; Danesi L; Cattaneo A; Sciortino G; Radin R; Ambrogio AG; Vitale G; D'Angelo E; Mirra N; Zanaboni L; Arvigo M; Boschetti M; Ferone D; Marzullo P; Baldini M; Cassinerio E; Cappellini MD; Persani L; Cavagnini F
    Endocrine; 2016 Aug; 53(2):551-7. PubMed ID: 26825070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender.
    Rota F; Savanelli MC; Tauchmanova L; Savastano S; Lombardi G; Colao A; Di Somma C
    J Endocrinol Invest; 2008 Feb; 31(2):94-102. PubMed ID: 18362499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
    Rhee EJ; Oh KW; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Park CY; Choi MG; Yoo HJ; Park SW
    J Bone Miner Metab; 2004; 22(4):392-8. PubMed ID: 15221500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men.
    Krassas GE; Papadopoulou P; Koliakos G; Konstantinidis T; Kalothetou K
    Arch Androl; 2003; 49(3):191-9. PubMed ID: 12746097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Bone Mineral Density in Middle-Aged Male Patients with Adult Growth Hormone Deficiency.
    Liu S; Yang H; Xu H; Zhou Z; Bai X; Wang L; Duan L; Gong F; Zhu H; Pan H
    Horm Metab Res; 2022 Jul; 54(7):450-457. PubMed ID: 35556240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density of young boy soccer players at different pubertal stages: relationships with hormonal concentration.
    Nebigh A; Rebai H; Elloumi M; Bahlous A; Zouch M; Zaouali M; Alexandre C; Sellami S; Tabka Z
    Joint Bone Spine; 2009 Jan; 76(1):63-9. PubMed ID: 18707910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.
    Gürlek A; Gedik O
    J Endocrinol Invest; 2001 Jun; 24(6):408-14. PubMed ID: 11434664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low bone mineral density in adults with previous hypothalamic-pituitary tumors: correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3.
    Bing-You RG; Denis MC; Rosen CJ
    Calcif Tissue Int; 1993 Mar; 52(3):183-7. PubMed ID: 7683247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis.
    Tritos NA; Greenspan SL; King D; Hamrahian A; Cook DM; Jönsson PJ; Wajnrajch MP; Koltowska-Häggstrom M; Biller BM
    J Clin Endocrinol Metab; 2011 May; 96(5):1516-23. PubMed ID: 21367928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study.
    Szulc P; Joly-Pharaboz MO; Marchand F; Delmas PD
    Calcif Tissue Int; 2004 Apr; 74(4):322-9. PubMed ID: 15255068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH-deficient adults.
    Clanget C; Seck T; Hinke V; Wüster C; Ziegler R; Pfeilschifter J
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):93-9. PubMed ID: 11453957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men.
    Gillberg P; Olofsson H; Mallmin H; Blum WF; Ljunghall S; Nilsson AG
    Calcif Tissue Int; 2002 Jan; 70(1):22-9. PubMed ID: 11907704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.